Plasma prolactin level and risk of incident hypertension in postmenopausal women.
BACKGROUND
Laboratory and cross-sectional human studies suggest a potential role for prolactin in the pathogenesis of hypertension; however, the prospective association between prolactin and hypertension has not been previously reported.


METHODS
We prospectively examined the association between daytime plasma prolactin levels and the risk of incident hypertension among 874 postmenopausal women who were participants of the Nurses' Health Study. Cox proportional hazards regression models were used to adjust for potential confounders.


RESULTS
We identified 183 incident cases of hypertension during 8 years of follow-up. After adjusting for potential confounders, the relative risk of hypertension for a 1-standard deviation higher plasma prolactin was 1.31 (95% confidence interval 1.05-1.62). Compared with women with plasma prolactin levels of 8.0 ng/ml or below, the multivariable relative risk of incident hypertension for those with prolactin levels above 8.0 ng/ml was 1.34 (95% confidence interval 0.90-1.99).


CONCLUSIONS
A higher daytime plasma prolactin level is independently associated with an increased risk of incident hypertension among postmenopausal women.
Zhang
Luxia
L
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. nhlzh@channing.harvard.edu
Curhan
Gary C
GC
Forman
John P
JP
D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000453:epidemiology*; D008875:Middle Aged; D017698:Postmenopause; D011388:Prolactin / Q000097:blood*; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012306:Risk; D013997:Time Factors
D011388:Prolactin
J Clin Endocrinol Metab. 2008 Jul;93(7):2492-9
18460570
Biol Reprod. 2000 Jun;62(6):1571-8
10819757
J Hypertens. 2003 Nov;21(11):1983-92
14597836
J Clin Oncol. 2007 Apr 20;25(12):1482-8
17372279
J Cell Physiol. 1991 Jul;148(1):133-8
1860893
Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8
16481882
Am J Epidemiol. 1986 May;123(5):894-900
3962971
Hypertension. 2009 Jul;54(1):98-105
19451414
Am J Kidney Dis. 1985 Oct;6(4):245-9
4050782
Am J Epidemiol. 1986 Jul;124(1):17-27
3521261
Nephrol Dial Transplant. 2003 Aug;18(8):1549-54
12897093
J Clin Endocrinol Metab. 2008 May;93(5):1655-61
18319308
Lancet. 1977 Jul 30;2(8031):211-4
69827
Endocr Rev. 2003 Feb;24(1):1-27
12588805
J Am Soc Nephrol. 2004 Jul;15(7):1897-903
15213279
Endocrinology. 2007 Aug;148(8):4080-90
17463060
Hypertension. 1995 Mar;25(3):305-13
7875754
Lab Invest. 2005 May;85(5):633-42
15753953
Cardiovasc Res. 1973 Sep;7(5):585-7
4753293
Arch Intern Med. 2004 Jul 26;164(14):1519-24
15277282
Hypertension. 2008 Apr;51(4):952-9
18259027
Arch Gynecol Obstet. 1988;243(2):83-90
3401043
Breast Cancer Res Treat. 2007 Nov;105(3):337-46
17260098
Am J Epidemiol. 1985 Jul;122(1):51-65
4014201
J Clin Endocrinol Metab. 1998 Mar;83(3):761-4
9506722
J Clin Endocrinol Metab. 1990 Jul;71(1):60-6
2370301
J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65
15601642